相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-κB inactivation
Dae-Seok Kim et al.
CANCER RESEARCH (2006)
Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-κB in cancer cells:: Delineation of a novel pathway
Aman P. Mann et al.
CANCER RESEARCH (2006)
Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth
R. A. Jones et al.
CELL DEATH AND DIFFERENTIATION (2006)
Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression
Lingbao Ai et al.
CANCER RESEARCH (2006)
GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis
Lei Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Implications of tissue transglutaminase expression in malignant melanoma
Jansina Y. Fok et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells
J. F. Herman et al.
ONCOGENE (2006)
Tissue transglutaminase serves as an inhibitor of aoptosis by cross-linking caspase 3 in thapsigargin-treated cells
H Yamaguchi et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Transforming growth factor-beta in cancer and metastasis
Sonia B. Jakowlew
CANCER AND METASTASIS REVIEWS (2006)
The role of tissue transglutaminase in cell-matrix interactions
EA Zemskov et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Tissue transglutaminase (TG2) - a wound response enzyme
D Telci et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Life in the balance: how BH3-only proteins induce apoptosis
SN Willis et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Tissue cells feel and respond to the stiffness of their substrate
DE Discher et al.
SCIENCE (2005)
DNA methylation and human disease
KD Robertson
NATURE REVIEWS GENETICS (2005)
Transglutaminase 2 in the balance of cell death and survival
L Fésüs et al.
FEBS LETTERS (2005)
Innovation - Detection and interpretation of altered methylation patterns in cancer cells
T Ushijima
NATURE REVIEWS CANCER (2005)
Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2
AW Adamson et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
The monofunctional alkylating agent N-methyl-N '-nitro-N-nitrosoguanidine triggers apoptosis through p53-dependent and -independent pathways
WJ Kim et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death
T Milakovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tissue transglutaminase is a multifunctional BH3-only protein
C Rodolfo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The ATM gene is a target for epigenetic silencing in locally advanced breast cancer
QN Vo et al.
ONCOGENE (2004)
Predicting aberrant CpG island methylation
FA Feltus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb.
JE Boehm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line
WJ Kim et al.
ONCOGENE (2002)
Chromatin remodeling: why it is important in cancer
AP Wolffe
ONCOGENE (2001)
Doxorubicin and paclitaxel in the treatment of advanced breast cancer: Efficacy and cardiac considerations
EA Perez
CANCER INVESTIGATION (2001)
分享论文
